Literature DB >> 21853002

A novel germline mutation of the VHL gene in a Greek family with Von Hippel-Lindau disease.

Melpomeni Peppa1, Smaragda Kamakari, Eleni Boutati, Panagiotis Nikolopoulos, Christoforos Giatzakis, Theofanis Economopoulos, Dimitrios Hadjidakis, Sotirios A Raptis.   

Abstract

Von Hippel-Lindau disease (VHL) is an autosomal dominant disorder, caused by mutations of the VHL gene showing a strong genotype-phenotype correlation. The present report concerns a 16-year-old girl with VHL (retinal, spinal cord and cerebellar haemangioblastomas and pancreatic cysts), her father (retinal and spinal cord haemangioblastomas) and the phenotypically healthy mother and younger brother and sister. DNA extraction, PCR and direct sequencing of the VHL entire coding and intronic flanking sequences, were performed according to standard procedures. In the index patient and her father a novel heterozygous germline was identified; nonsense mutation (p.145X) in exon 2 of VHL, leading to a truncated VHL protein lacking the last 66 amino acids. This is the first report of a novel VHL mutation in patients with VHL associated with haemangioblastomas and pancreatic cysts but not renal cell carcinoma.

Entities:  

Year:  2009        PMID: 21853002      PMCID: PMC3029452          DOI: 10.1136/bcr.02.2009.1574

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex.

Authors:  Felicia Miller; Alex Kentsis; Roman Osman; Zhen-Qiang Pan
Journal:  J Biol Chem       Date:  2004-12-20       Impact factor: 5.157

Review 2.  Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment.

Authors:  Taro Shuin; Ichiro Yamasaki; Kenji Tamura; Heiwa Okuda; Mutsuo Furihata; Shingo Ashida
Journal:  Jpn J Clin Oncol       Date:  2006-06       Impact factor: 3.019

Review 3.  Renal cysts, renal cancer and von Hippel-Lindau disease.

Authors:  H P Neumann; B Zbar
Journal:  Kidney Int       Date:  1997-01       Impact factor: 10.612

4.  Genotype-phenotype correlations in von Hippel-Lindau disease.

Authors:  Kai Ren Ong; Emma R Woodward; Pip Killick; Caron Lim; Fiona Macdonald; Eamonn R Maher
Journal:  Hum Mutat       Date:  2007-02       Impact factor: 4.878

5.  Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC.

Authors:  C Gallou; D Joly; A Méjean; F Staroz; N Martin; G Tarlet; M T Orfanelli; R Bouvier; D Droz; Y Chrétien; J M Maréchal; S Richard; C Junien; C Béroud
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

6.  Clinical features and natural history of von Hippel-Lindau disease.

Authors:  E R Maher; J R Yates; R Harries; C Benjamin; R Harris; A T Moore; M A Ferguson-Smith
Journal:  Q J Med       Date:  1990-11

7.  Identification of the von Hippel-Lindau disease tumor suppressor gene.

Authors:  F Latif; K Tory; J Gnarra; M Yao; F M Duh; M L Orcutt; T Stackhouse; I Kuzmin; W Modi; L Geil
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

8.  Structural bioinformatics mutation analysis reveals genotype-phenotype correlations in von Hippel-Lindau disease and suggests molecular mechanisms of tumorigenesis.

Authors:  Julia R Forman; Catherine L Worth; G Richard J Bickerton; Tim G Eisen; Tom L Blundell
Journal:  Proteins       Date:  2009-10

9.  Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.

Authors:  F Chen; T Kishida; M Yao; T Hustad; D Glavac; M Dean; J R Gnarra; M L Orcutt; F M Duh; G Glenn
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

10.  Von Hippel-Lindau disease: a genetic study.

Authors:  E R Maher; L Iselius; J R Yates; M Littler; C Benjamin; R Harris; J Sampson; A Williams; M A Ferguson-Smith; N Morton
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

View more
  1 in total

1.  Clinical presentation and mutation analysis of VHL disease in a large Chinese family.

Authors:  Qing Zhang; De-Ling Li; Peng Kang; Nan Ji; Jun Yang; Wei-Ming Liu; Li-Wei Zhang; Gui-Jun Jia
Journal:  J Neurooncol       Date:  2015-09-04       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.